Spanish Registry of Digestive Tumours RETUD

Last updated: November 27, 2024
Sponsor: Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)
Overall Status: Active - Recruiting

Phase

N/A

Condition

Rectal Cancer

Pancreatic Cancer

Digestive System Neoplasms

Treatment

N/A

Clinical Study ID

NCT06711211
TTD-20-01 RETUD RETUD
  • Ages > 18
  • All Genders

Study Summary

The aim of this observational study is to assess the current state of digestive tumours in Spain. By doing so, it seeks to enhance the quality of care, optimize the diagnosis and treatment of digestive tumours, and identify opportunities for improvement that can benefit patients.

The study will investigate the epidemiological, biological, and clinical characteristics of digestive tumors diagnosed in patients aged 18 and older across healthcare centres in Spain. It also aims to generate knowledge and scientific evidence for events and situations that may impact on patients with digestive tumours (e.g. COVID-19 coronavirus pandemic).

Furthermore, subject to the patient's consent, biological samples may be collected for use in translational research projects and for the identification of molecular markers that may be useful in healthcare decision-making.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Male and female patients ≥18 years old diagnosed with oesophageal cancer, gastriccancer, pancreatic cancer, hepatocarcinoma, gallbladder and bile duct cancer, cancerof the small intestine, appendix and gastrointestinal stroma, colorectal cancer,anal canal cancer or digestive hereditary cancer.

  • Written informed consent available.

Exclusion

Exclusion Criteria:

  • Patient for whom, for whatever reason, it is not possible to know or obtain theinformation necessary to complete the data collection base.

Study Design

Total Participants: 20000
Study Start date:
December 23, 2020
Estimated Completion Date:
December 31, 2030

Study Description

Data will be collected ambispectively, recording those patients who were diagnosed with digestive tumours before the start of the study (from 2017) and also those who are diagnosed after the start of the study.

Connect with a study center

  • Grupo de Tratamiento de los Tumores Digestivos (TTD)

    Madrid, 28007
    Spain

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.